FDA approves Boostrix for older people
The U.S. Food and Drug Administration (FDA) has approved the Boostrix vaccine to prevent tetanus, diphtheria, and pertussis in people 65 years and older. Read more.
Reader Survey
Please share your feedback! We’re interested to learn more about your experience with American Nurse Journal.
